SRINIVAS AKKARAJU Insider Trading $ARAV Aravive, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for SRINIVAS AKKARAJU.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of SRINIVAS AKKARAJU. SRINIVAS AKKARAJU is Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in aTYR PHARMA INC ($LIFE) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in ZS Pharma, Inc. ($ZSPH) and Director in Principia Biopharma Inc. ($PRNB) and Director in Versartis, Inc. ($VSAR) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Jiya Acquisition Corp. ($JYAC).

SRINIVAS AKKARAJU in Aravive, Inc.

Trading Symbol: ARAV
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SRINIVAS AKKARAJU: Director
Holdings: 576,066 shares
Current Value: $7,661,678
Latest Transaction: Dec 02 2019
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of SRINIVAS AKKARAJU in Aravive, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARAV, LIFE, ADRO, ICPT, JYAC, PRNB, SGEN, SYRS, ZSPH

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 02 2019ARAVAravive, Inc.AKKARAJU SRINIVASDirectorBuyP7.50133,333999,998576,066442.7 K to 576.1 K (+30.12 %)
Sep 13 2019ARAVAravive, Inc.AKKARAJU SRINIVASDirectorOption ExerciseA5.777,50043,2757,500
Jan 07 2019VSARAravive, Inc.AKKARAJU SRINIVASDirectorOption ExerciseA3.694,68817,2994,688
Oct 16 2018VSARAravive, Inc.AKKARAJU SRINIVASDirectorGrantA0.0027,456031,8154.4 K to 31.8 K (+629.87 %)
Jun 15 2018VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP2.1353,018112,9282,682,5542.6 M to 2.7 M (+2.02 %)
Jun 15 2018VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP2.1353,018112,9282,682,5542.6 M to 2.7 M (+2.02 %)
Jun 08 2018VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP2.00231,580463,1602,629,5362.4 M to 2.6 M (+9.66 %)
Jun 08 2018VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP1.85163,224301,9642,397,9562.2 M to 2.4 M (+7.30 %)
Jun 08 2018VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP1.74660,6811,149,5852,234,7321.6 M to 2.2 M (+41.97 %)
Dec 22 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorGrantA0.0011,200026,15515 K to 26.2 K (+74.89 %)
Dec 05 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP2.0042,89585,7901,547,8961.5 M to 1.5 M (+2.85 %)
Dec 05 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP2.21513,8721,135,6571,505,001991.1 K to 1.5 M (+51.85 %)
Dec 05 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP2.13419,700893,961991,129571.4 K to 991.1 K (+73.45 %)
Jun 06 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorOption ExerciseA15.836,850108,4016,850
Jun 06 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorGrantA0.003,480014,95511.5 K to 15 K (+30.33 %)
Mar 28 2017VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP12.25571,4297,000,005571,4290 to 571.4 K
Oct 04 2016VSARVersartis, Inc.AKKARAJU SRINIVASDirectorBuyP12.25571,4297,000,005571,4290 to 571.4 K
Jun 20 2016VSARVersartis, Inc.AKKARAJU SRINIVASDirectorOption ExerciseA10.8728,720312,18628,720
Jun 20 2016VSARVersartis, Inc.AKKARAJU SRINIVASDirectorGrantA0.006,900011,4754.6 K to 11.5 K (+150.82 %)
Jul 01 2015VSARVersartis, Inc.AKKARAJU SRINIVASDirectorOption ExerciseA14.7313,100192,96313,100
Jul 01 2015VSARVersartis, Inc.AKKARAJU SRINIVASDirectorGrantA0.004,57504,5750 to 4.6 K

Page:   1